Influence of Biosimilar Infliximab Launch on the Utilization Pattern of Biological Medicines: The Case of Hungary
Expert Review of Pharmacoeconomics and Outcomes Research - United Kingdom
doi 10.1080/14737167.2019.1667232
Full Text
Open PDFAbstract
Available in full text
Date
September 18, 2019
Authors
Publisher
Informa UK Limited